Variation in effects of Non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Wang, Sophia S ^a   Lu, Yani ^a   Rothman, Nathaniel ^b   Abdou, Amr M ^c   Cerhan, James R ^d   de Roos, Anneclaire ^e   Davis, Scott ^e   Severson, Richard K ^f   Cozen, Wendy ^g   Chanock, Stephen J ^b   Bernstein, Leslie ^a   Morton, Lindsay M ^b   Hartge, Patricia ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; INSECTICIDE; POLYCHLORINATED BIPHENYL; HLA DRB1 ANTIGEN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HLA GENE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; RISK ASSESSMENT; RISK FACTOR; SUN EXPOSURE; UNITED STATES; ALLELE; CONFIDENCE INTERVAL; GENETICS; GENOTYPE; MIDDLE AGED;

ISOPTERA;

ADULT; AGED; ALLELES; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 80655139024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026949     Document Type: Article

References (26)

1. Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, et al. (2009) Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125: 398-405.
2. Devlin JF, (2003) A spreadsheet method of estimating best-fit hydraulic gradients using head data from multiple wells. Ground Water 41: 316-320.
3. Shiina T, Hosomichi K, Inoko H, Kulski JK, (2009) The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54: 15-39.
4. Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, et al. (2010) Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 42: 661-664.
5. Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, et al. (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 66: 9771-9780.
6. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjose S, et al. (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171: 267-276.
7. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, et al. (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7: 27-38.
8. Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, et al. (2007) Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 67: 5042-5054.
9. Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, et al. (2010) Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia 24: 1055-1058.
10. Candore G, Lio D, Colonna Romano G, Caruso C, (2002) Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 1: 29-35.
11. Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, et al. (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111: 4029-4038.
12. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, et al. (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6: 451-458.
13. Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, et al. (2007) Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 109: 3479-3488.
14. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, et al. (2005) Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 14: 925-933.
15. Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, et al. (2008) Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 122: 2062-2070.
16. Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, et al. (2005) Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 6: 469-476.
17. Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, et al. (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 122: 144-154.
18. Colt JS, Rothman N, Severson RK, Hartge P, Cerhan JR, et al. (2009) Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood 113: 1899-1905.
19. Colt JS, Severson RK, Lubin J, Rothman N, Camann D, et al. (2005) Organochlorines in carpet dust and non-Hodgkin lymphoma. Epidemiology 16: 516-525.
20. Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, et al. (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112: 5150-5160.
21. Percy CVH, V; Muir C, eds. (1990) International Classification of Diseases for Oncology. 2nd ed Geneva World Health Organization.
22. Hurley MTJHC, (2002) IHWG Technical manual: Genomic Analysis of the Human MHC Seattle, WA.
23. De Roos AJ, Hartge P, Lubin JH, Colt JS, Davis S, et al. (2005) Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res 65: 11214-11226.
24. Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, et al. (2010) Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 58-69.
25. Purdue MP, Hartge P, Davis S, Cerhan JR, Colt JS, et al. (2007) Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control 18: 989-999.
26. Gathany AH, Hartge P, Davis S, Cerhan JR, Severson RK, et al. (2009) Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control 20: 1291-1302.